• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

What Does Cannabis 3.0 Actually Mean?

LOS ANGELES- If Cannabis 1.0 was legalization and survival, and Cannabis 2.0 was scale and brand proliferation, Cannabis 3.0 is something far more structural. It is the shift from product velocity to process discipline. From ...

Organigram Strikes Deal to Acquire Sanity Group

TORONTO-BERLIN – Organigram Global Inc. has signed a definitive agreement to purchase the remaining shares of Berlin-based Sanity Group GmbH that it does not already hold. The transaction builds on Organigram's earlier minority stake and ...

Innovia Consulting Acquires 365 Cannabis

ONALASKA – Innovia Consulting, a longtime provider of Microsoft Dynamics 365 Business Central services, has acquired 365 Cannabis along with its sister entity 365Vertical. The deal brings in two Microsoft partners that focus on customized ...

Village Farms Takes Top Honor at BC Export Awards

VANCOUVER – Village Farms International Inc. secured the 2026 BC Export Award in the Consumer Products category, presented by Business in Vancouver. The recognition highlights the company's sharp rise in international sales, with exports jumping ...

SAM in Action: How Dark Money Fuels Prohibitionists Attacks

LOS ANGELES – A noticeable uptick in anti-Cannabis content has appeared on social platforms lately, flooding threads with posts on scromiting, schizophrenia, psychosis risks, outdated research, recycled study headlines, and new ballot proposals surfacing in ...

CMS Finalizes Rule for Medicare CBD Coverage Pilot

WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has finalized regulations enabling a pilot program for federal health insurance coverage of hemp-derived CBD products, according to a recent statement from an executive at ...

Missouri Cannabis Sales Hit Record $1.5B in 2025

JEFFERSON CITY – Missouri's regulated Cannabis market posted its strongest year yet in 2025, with retailers recording approximately $1.5 billion in total sales, according to figures from the Missouri Department of Health and Senior Services. ...

MindMed to Present at Key September Investor Conferences

LOS ANGELES- Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for brain health disorders, announced its participation in three significant investor conferences in September 2024. MindMed’s management team will engage ...

Subscribe To Our Newsletter

Go to Top